| 1 |
31768675 | Sequential therapy of four cycles of bortezomib, melphalan, and prednisolone followed by continuous lenalidomide and dexamethasone for transplant-ineligible newly diagnosed multiple myeloma. | 2020 Jan |
1 |
| 2 |
28906482 | Real‑life experience with bortezomib‑based regimens in elderly patients with newly diagnosed multiple myeloma and comorbidities: a Polish retrospective multicenter study. | 2017 Nov 30 |
1 |
| 3 |
24849305 | [Clincal features and treatment of multiple myeloma]. | 2014 Jun |
1 |
| 4 |
19858394 | VMP (Bortezomib, Melphalan, and Prednisone) is active and well tolerated in newly diagnosed patients with multiple myeloma with moderately impaired renal function, and results in reversal of renal impairment: cohort analysis of the phase III VISTA study. | 2009 Dec 20 |
1 |